We discuss coronavirus, cancer drugs, gene therapies, crispr and related biotech stocks & ETFs.
(1:20) - Who Could Benefit From A Coronavirus Treatment?
(5:45) - What Should Investors Expect From Biotech In 2020?
(10:50) - Will The FDA Approve Biogen’s New Alzheimer’s Drug?
(15:00) - New and Exciting Cancer Treatments
(22:15) - CRISPR: Is 2020 The Year For Gene Therapy?
(32:40) - Merck’s Product Spin Off
Podcast@Zacks.com
